CIPO Patents = 1

EPO Patents = 5

Forward Citations = 6

Loading Chart...

4 inventors (with patents filed for the assignee):

Dirk Roggenbuck (3 out of 6 patents)

Cläre Von Neubeck (1 out of 1 patent)

Rico Hiemann (1 out of 1 patent)

4. Alexey Elimport (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 11549952 - Method for the diagnosis of acute pancreatitis (AP) by detection of glycoprotein 2 isoform alpha (GP2A) (2023-01-10),

2. 11340235 - GP2 isoforms and their use in autoantibody capture (2022-05-24),

3. 11238581 - Method, system and computer program for computer-assisted evaluation of biomarkers in a tissue sample (2022-02-01),

4. 8058019 - Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis (2011-11-15),

Company Overview

Ga Generic Assays Gmbh is a leading provider of innovative in vitro diagnostic test solutions for clinical laboratories, hospitals, and research institutions worldwide. With a focus on high quality, reliability, and efficiency, we offer a wide range of assays for various disease markers and conditions. Our team of experienced scientists and experts are dedicated to developing cutting-edge solutions for better healthcare outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#1 in Dahlewitz

#7,035 in Germany

Dahlewitz, Germany

Ga Generic Assays Gmbh

Forward Citations = 6

4 inventors:

Dirk Roggenbuck (3 out of 6 patents)

Cläre Von Neubeck (1 out of 1 patent)

Rico Hiemann (1 out of 1 patent)

4. Alexey Elimport (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ga Generic Assays Gmbh. Retrieved from https://idiyas.com/company/ga-generic-assays

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]